Management of Brain Metastasis and Adrenal Insufficiency

Introduction to Corticosteroid Therapy

Dexamethasone is the preferred corticosteroid for cerebral edema management due to its potent anti-inflammatory effects, minimal mineralocorticoid activity, and superior penetration of the blood-brain barrier, as recommended by the American College of Oncology 1, 2
Hydrocortisone is the drug of choice for adrenal insufficiency because it most closely mimics physiologic cortisol and provides both glucocorticoid and mineralocorticoid effects needed for replacement 3

The recommended dose for mild symptoms is 4-8 mg/day of hydrocortisone or dexamethasone, depending on the condition being treated, while moderate to severe symptoms require 16 mg/day, and up to 100 mg/day in divided doses may be needed for severe symptoms with risk of herniation 4, 2, 5
Corticosteroids should be administered in the morning and early afternoon to minimize sleep disturbance, and nighttime doses should be avoided to minimize toxicity 5
Tapering corticosteroids as rapidly as clinically tolerated is recommended to minimize the risk of complications 5

Maintenance therapy for adrenal insufficiency typically consists of 10-20 mg orally of hydrocortisone in the morning and 5-10 mg orally in the early afternoon, with doses increased to 2-3 times the maintenance dose during stress or illness, and up to 100 mg IV hydrocortisone for severe illness or surgery 3

Patients should start corticosteroids several days before thyroid hormone replacement to minimize the risk of complications, and all patients need education on stress dosing and should wear a medical alert bracelet for adrenal insufficiency 3
Endocrine consultation is recommended prior to surgery or procedures for stress-dose planning to ensure adequate corticosteroid coverage 3

Abrupt discontinuation of dexamethasone can precipitate adrenal crisis in patients with adrenal insufficiency, and should be tapered slowly over 1-2 weeks when discontinuing, as recommended by the American College of Oncology 1, 2
Long-term steroid use is associated with significant side effects, including pneumocystis jiroveci pneumonia, diabetes, hyperglycemia, arterial hypertension, osteoporosis, myopathy, and psychiatric adverse effects, and may be linked to inferior survival in glioblastoma patients and interfere with immunotherapy approaches 1
Prolonged use of dexamethasone may require prophylaxis with trimethoprim-sulfamethoxazole to prevent pneumocystis jiroveci pneumonia, and current evidence does not support the routine use of alternatives to dexamethasone 1

Prophylactic use of steroids is discouraged, and antiparasitic drugs should be avoided in patients with diffuse cerebral edema, as stated by the American College of Oncology and the Infectious Diseases Society of America 1, 6
The American College of Oncology recommends dexamethasone as the corticosteroid of choice for the treatment of symptomatic cerebral edema associated with brain tumors, with no absolute contraindication for its use in these cases, although it should be administered only to symptomatic patients and at the minimum effective dose to control neurological symptoms 1